Pharmaresearch Bio Co (XKRX:217950) ROE % Adjusted to Book Value : 6.69% (As of Dec. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co ROE % Adjusted to Book Value?

Pharmaresearch Bio Co's ROE % for the quarter that ended in Dec. 2024 was 26.31%. Pharmaresearch Bio Co's PB Ratio for the quarter that ended in Dec. 2024 was 3.93. Pharmaresearch Bio Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 6.69%.

Pharmaresearch Bio Co ROE % Adjusted to Book Value Historical Data

The historical data trend for Pharmaresearch Bio Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co ROE % Adjusted to Book Value Chart

Pharmaresearch Bio Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

0.04

2.06

8.32

3.46

6.69

Pharmaresearch Bio Co Semi-Annual Data
	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23	Dec24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial			0.04	2.06	8.32	3.46	6.69

Competitive Comparison of Pharmaresearch Bio Co's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Pharmaresearch Bio Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmaresearch Bio Co's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharmaresearch Bio Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Pharmaresearch Bio Co's ROE % Adjusted to Book Value falls into.

Save Embed

;

Save Embed

;

Pharmaresearch Bio Co ROE % Adjusted to Book Value Calculation

Pharmaresearch Bio Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	26.31%	/	3.93
	=	6.69%

Pharmaresearch Bio Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	26.31%	/	3.93
	=	6.69%

Pharmaresearch Bio Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharmaresearch Bio Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494

Website

http://www.pr-bio.co.kr

Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co Headlines

No Headlines